NasdaqCM - Delayed Quote USD

Check-Cap Ltd. (CHEK)

2.1800 +0.0100 (+0.46%)
At close: May 13 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Alex Ovadia CEO & Director 409.35k -- 1962
Dr. Yoav Kimchy Ph.D. Founder & Interim CTO 362.65k -- 1961
Mr. Joshua Belkar Vice President of Operations 269.57k -- 1969
Ms. Iris Even-Tov Interim Chief Financial Officer -- -- --
Ms. Noa Reshef M.B.A. Director of Human Resources -- -- --

Check-Cap Ltd.

Check-Cap Building
29 Abba Hushi Avenue PO Box 1271
Isfiya, 3009000
Israel
972 4 830 3401 https://www.check-cap.com
Sector: 
Healthcare
Full Time Employees: 
85

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Corporate Governance

Check-Cap Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 01, 2024
    NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
    See Full Filing
  • Apr 29, 2024
    6-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 15, 2024
    6-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 10, 2024
    6-K/A: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 08, 2024
    6-K: Corporate Changes & Voting Matters
    See Full Filing

Upcoming Events

Jul 30, 2024 - Aug 05, 2024
Check-Cap Ltd. Earnings Call

Related Tickers

SKHCF Sonic Healthcare Limited
18.26
+0.19%
 
OCX OncoCyte Corporation
2.8850
-0.17%
 
TTOO T2 Biosystems, Inc.
4.3900
+18.81%
 
BIAF bioAffinity Technologies, Inc.
1.9900
-0.50%
 
THOXF BioPorto A/S
0.3100
0.00%
 
6847.TWO Puriblood Medical Co., Ltd.
110.50
-0.90%
 
IDTA IDenta Corp.
0.2175
0.00%
 
HTGMQ HTG Molecular Diagnostics, Inc.
0.0015
-40.00%
 
SYAB.DE SYNLAB AG
10.30
+0.19%
 
CORBF Global Cord Blood Corporation
1.2500
0.00%